A Risk Versus Reward Approach to Market Research Custom Case Solution & Analysis

1. Evidence Brief

Financial Metrics

Operational Facts

• The product development cycle requires 14 months from inception to shelf.
• Manufacturing capacity is currently at 78 percent utilization.
• Distribution agreements cover 12,000 retail locations in the primary region.
• The marketing department has three active campaigns running simultaneously.

Stakeholder Positions

• Director of Marketing: Advocates for full research to mitigate career risk and secure budget approval.
• Chief Financial Officer: Skeptical of research delays and prefers immediate launch to capture seasonal demand.
• Product Manager: Expresses concern over competitor speed and potential loss of first-mover advantage.
• Research Vendor: Claims high reliability but refuses to guarantee results or provide raw data access.

Information Gaps

• The case does not specify the cost of capital used for Net Present Value calculations.
• Competitor reaction times to a new product launch are not quantified.
• The specific impact of a six-week research delay on seasonal sales remains unstated.

2. Strategic Analysis

Core Strategic Question

• Does the expected value of information provided by the 150,000 USD market research study outweigh the costs of delay and the risk of a false negative result?

Structural Analysis

Application of Expected Value of Information (EVOI) reveals a clear mathematical path. Without research, the expected value of the launch is 3,475,000 USD. With research, the probability of avoiding the 3,500,000 USD loss increases significantly. The calculation indicates the research is worth up to 420,000 USD before it becomes value-dilutive. Therefore, the current price of 150,000 USD is economically sound.

Using the Jobs-to-be-Done lens, the consumer is seeking a convenient meal replacement. The current data suggests a 45 percent fit. The research serves to confirm if the product features meet the specific functional requirements of the target demographic before committing major capital.

Strategic Options

• Option 1: Immediate Launch. This skips the 150,000 USD cost and the six-week delay. It captures the seasonal window but carries a 55 percent chance of a 3,500,000 USD loss.
  • Trade-off: Speed versus risk exposure.
  • Resources: Full capital expenditure of 4,500,000 USD required immediately.
• Option 2: Conduct Research then Decide. This uses the 150,000 USD to refine the decision. It delays the launch but provides an 82 percent accuracy rate for the final decision.
  • Trade-off: Cost and time versus decision confidence.
  • Resources: 150,000 USD for the study and internal management time.
• Option 3: Pilot Launch in a Restricted Geography. Launch in 500 stores instead of 12,000.
  • Trade-off: Lower risk but slower scaling and higher per-unit costs.
  • Resources: 1,000,000 USD initial investment.

Preliminary Recommendation

The company should proceed with Option 2. The cost of the research is less than 4 percent of the total launch capital. Given the high failure cost of 3,500,000 USD, the research acts as an essential insurance policy. The mathematical expected value increases by over 200,000 USD when research is included in the decision process.

3. Implementation Planning

Critical Path

• Week 1: Finalize research methodology and sign vendor contract.
• Weeks 2-5: Data collection and consumer focus groups across three key demographics.
• Week 6: Data synthesis and presentation of go or no-go recommendation.
• Week 7: Executive committee final vote on capital allocation.
• Week 8: If go, trigger manufacturing procurement and media buy.

Key Constraints

• Vendor Reliability: The 82 percent accuracy rate depends on the vendor ability to reach a representative sample. Any deviation will invalidate the decision model.
• Seasonal Window: The six-week delay puts the launch at the end of the peak buying season. Manufacturing must be ready to scale instantly if the research is positive.

Risk-Adjusted Implementation Strategy

To mitigate the delay, the company will begin parallel processing. While research is conducted, the legal and procurement teams will prepare contracts that can be executed within 24 hours of a positive decision. This reduces the total time-to-market by two weeks compared to a sequential process. If the research indicates a failure probability above 60 percent, the project will be terminated immediately to preserve the 4,500,000 USD capital for alternative initiatives.

4. Executive Review and BLUF

BLUF

The company must authorize the 150,000 USD market research study immediately. The financial downside of a failed launch is 3,500,000 USD, which represents 77 percent of the total capital expenditure. The research provides a 37 percent improvement in decision accuracy for a cost equal to 3.3 percent of the launch budget. Delaying the launch by six weeks is a necessary cost to avoid a high-probability capital loss. Proceed with research and prepare for a rapid manufacturing ramp-up in week seven if results confirm market fit.

Dangerous Assumption

The analysis assumes that the historical 82 percent research accuracy will hold for this specific product category. If the product is a novel innovation, consumer self-reporting in research settings is notoriously unreliable, potentially leading to a false positive that results in a full 4,500,000 USD loss despite the research.

Unaddressed Risks

• Competitor Preemption: A six-week delay allows the primary competitor to launch their similar product first, potentially capturing the 12,000 retail slots and making the research findings irrelevant. Probability: Moderate. Consequence: Severe.
• Internal Resource Drain: Focusing the marketing team on a six-week research project may distract from current top-performing products, leading to a decline in existing revenue streams. Probability: High. Consequence: Moderate.

Unconsidered Alternative

The team did not consider a licensing model. Instead of launching and manufacturing internally, the company could license the product formulation to a larger competitor with existing excess capacity. This would eliminate the 4,500,000 USD capital risk and the need for research, replacing it with a lower but guaranteed royalty stream.

Verdict

APPROVED FOR LEADERSHIP REVIEW